aecifo

The Venture Capitalists Behind the 5 Biggest Health Tech Deals

Umito October 30, 2024

Health tech investments are showing signs of resilience after the perilous lows of 2022 and 2023: Last month, two startups that analysts said could be gearing up for an IPO raised more than $100 million. dollars in late-stage financing rounds. And trading volume hit a record high in the second quarter, driven largely by early-stage deals, according to a Silicon Valley Bank Analysis.

Mega deals – those that bring in more than $100 million in venture capital – are still relatively rare. And “the bar for success has undoubtedly been raised,” according to Bessemer Venture Partners. “Investors are demanding clearer paths to profitability, more efficient growth and a differentiated path to value creation. »

Who are these investors and what exactly are they looking for? STAT tracked down the managing directors and general partners behind some of healthtech’s recent and largest venture capital deals, including Maven Clinic, which raised $125 million in a round tabletop series F, and Glooko, a digital diabetes care company that raised $100 million on its own. Series F in October – to find out what types of companies impress venture capitalists. These are the people who scoured the market for potential targets, did their due diligence, and ultimately signed the checks.

Exclusive STAT+ story

STAT+